Home > Cashflow Statement > LACTOSE (INDIA)

LACTOSE (INDIA)
Cashflow Statement

LACTOSE (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for LACTOSE (INDIA)
Please provide your vote to see the results

LACTOSE (INDIA) Last 5 Year Cashflow Statement History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹6.92 Cr₹9.66 Cr₹1.46 Cr₹3.17 Cr₹-3.27 Cr
Adjustment ₹10 Cr₹9.94 Cr₹11 Cr₹9.60 Cr₹9.85 Cr
Changes In working Capital ₹-16 Cr₹-10 Cr₹-4.13 Cr₹-4.36 Cr₹-4.44 Cr
Cash Flow after changes in Working Capital ₹0.84 Cr₹9.52 Cr₹7.94 Cr₹8.40 Cr₹2.13 Cr
Cash Flow from Operating Activities ₹-0.29 Cr₹8.75 Cr₹7.89 Cr₹8.47 Cr₹2.17 Cr
Cash Flow from Investing Activities ₹-16 Cr₹-2.08 Cr₹-0.92 Cr₹-0.56 Cr₹-6.18 Cr
Cash Flow from Financing Activities ₹19 Cr₹-5.72 Cr₹-8.32 Cr₹-8.14 Cr₹4.52 Cr
Net Cash Inflow / Outflow ₹2.95 Cr₹0.95 Cr₹-1.34 Cr₹-0.24 Cr₹0.51 Cr
Opening Cash & Cash Equivalents ₹1.53 Cr₹0.58 Cr₹1.92 Cr₹2.16 Cr₹1.65 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹4.48 Cr₹1.53 Cr₹0.58 Cr₹1.92 Cr₹2.16 Cr

Compare Cashflow Statement of peers of LACTOSE (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LACTOSE (INDIA) ₹124.5 Cr -4.8% -7.2% 2.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,195.0 Cr 1.8% 9% 12.5% Stock Analytics
DIVIS LABORATORIES ₹180,823.0 Cr 0.8% 0.8% -1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹165,725.0 Cr 2.8% 9.5% 45.4% Stock Analytics
CIPLA ₹116,467.0 Cr -1.2% 4.7% -4.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,987.0 Cr -7.6% 0.1% 6.1% Stock Analytics


LACTOSE (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
LACTOSE (INDIA)

-4.8%

-7.2%

2.5%

SENSEX

-1%

4.4%

-8.3%


You may also like the below Video Courses